Cargando…
Expression Cloning and Production of Human Heavy-Chain-Only Antibodies from Murine Transgenic Plasma Cells
Several technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems. For conventional antibodies, this involves either random pairing of VH and variable light (VL...
Autores principales: | Drabek, Dubravka, Janssens, Rick, de Boer, Ernie, Rademaker, Rik, Kloess, Johannes, Skehel, John, Grosveld, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165034/ https://www.ncbi.nlm.nih.gov/pubmed/28066429 http://dx.doi.org/10.3389/fimmu.2016.00619 |
Ejemplares similares
-
An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile
por: Gan, Xin, et al.
Publicado: (2022) -
Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants
por: Du, Wenjuan, et al.
Publicado: (2023) -
Heavy chain–only antibodies are spontaneously produced in light chain–deficient mice
por: Zou, Xiangang, et al.
Publicado: (2007) -
Somatic hypermutation of an immunoglobulin mu heavy chain transgene
Publicado: (1993) -
Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus
por: Xu, Shu, et al.
Publicado: (2020)